- Home
- TACH vs SENS Comparison
TACH vs SENS Comparison
Compare TACH & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACH
- SENS
- Stock Information
- Founded
- TACH 2024
- SENS 1996
- Country
- TACH United States
- SENS United States
- Employees
- TACH N/A
- SENS N/A
- Industry
- TACH
- SENS Industrial Machinery/Components
- Sector
- TACH
- SENS Industrials
- Exchange
- TACH Nasdaq
- SENS Nasdaq
- Market Cap
- TACH 351.2M
- SENS 360.5M
- IPO Year
- TACH 2025
- SENS N/A
- Fundamental
- Price
- TACH $10.19
- SENS $7.12
- Analyst Decision
- TACH
- SENS Strong Buy
- Analyst Count
- TACH 0
- SENS 6
- Target Price
- TACH N/A
- SENS $28.67
- AVG Volume (30 Days)
- TACH 133.6K
- SENS 707.8K
- Earning Date
- TACH 01-01-0001
- SENS 11-05-2025
- Dividend Yield
- TACH N/A
- SENS N/A
- EPS Growth
- TACH N/A
- SENS N/A
- EPS
- TACH 0.19
- SENS N/A
- Revenue
- TACH N/A
- SENS $25,466,000.00
- Revenue This Year
- TACH N/A
- SENS $62.96
- Revenue Next Year
- TACH N/A
- SENS $72.62
- P/E Ratio
- TACH $53.35
- SENS N/A
- Revenue Growth
- TACH N/A
- SENS 5.94
- 52 Week Low
- TACH $10.00
- SENS $5.00
- 52 Week High
- TACH $10.38
- SENS $28.00
- Technical
- Relative Strength Index (RSI)
- TACH N/A
- SENS 76.72
- Support Level
- TACH N/A
- SENS $6.98
- Resistance Level
- TACH N/A
- SENS $7.56
- Average True Range (ATR)
- TACH 0.00
- SENS 0.44
- MACD
- TACH 0.00
- SENS 0.50
- Stochastic Oscillator
- TACH 0.00
- SENS 80.30
About TACH Titan Acquisition Corp. Class A Ordinary Shares
Titan Acquisition Corp is a blank check company.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.